SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 12/14/2017 6:14:20 PM - Followers: 33 - Board type: Free - Posts Today: 0
SureTrader
Interactive Brokers Advertisement
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: Merck Provides Update on KEYNOTE-061, a Phase 3 Study of KEYTRUDA® (pembrolizumab) in Previously Treated Patients with Gastr... 12/14/2017 04:45:00 PM
MRK News: PREVYMIS™ (létermovir) offert au Canada à la fin décembre 2017 pour la prophylaxie d'une infection à cytomégalovirus (... 12/14/2017 01:20:00 PM
MRK News: PREVYMIS™ (letermovir) Available in Canada in Late December 2017 for the Prophylaxis of Cytomegalovirus (CMV) Infection in ... 12/14/2017 01:19:00 PM
MRK News: FDA Accepts Supplemental Biologics License Application (sBLA), Assigns Priority Review to Merck’s KEYTRUDA® (pembrolizumab... 12/11/2017 06:30:00 AM
MRK News: New England Journal of Medicine Publishes Phase 3 Clinical Study of PREVYMIS™ (letermovir), Merck’s New CMV Prophylaxis M... 12/06/2017 05:02:00 PM
PostSubject
#337  Sticky Note MRK’s 3Q17 results: DewDiligence 10/27/17 01:21:11 PM
#346   Keytruda trial in second-line gastric cancer does not DewDiligence 12/14/17 06:14:19 PM
#345   Has moved above its one year target, but r clarke 12/06/17 04:41:33 PM
#344   FDA approves MRK’s Prevymis (letermovir) for prevention of DewDiligence 11/09/17 10:32:32 AM
#343   https://www.bloomberg.com/gadfly/amp/articles/2017-10-30/merck-delays-keytruda-c north40000 11/01/17 01:53:44 AM
#342   stock market Up %25... This year ..MRK down kubis 10/31/17 07:29:50 AM
#341   Transcript of MRK 3Q17 CC: DewDiligence 10/30/17 11:39:20 AM
#340   Stocks aren't linear but if you go back S60guy 10/30/17 06:25:12 AM
#339   check the chart, MRK was $93 a share shotgun 10/29/17 02:25:32 PM
#338   MRK withdraws EU application for Keytruda/chemo in first-line NSCLC: DewDiligence 10/27/17 04:47:54 PM
#337   MRK’s 3Q17 results: DewDiligence 10/27/17 01:21:11 PM
#336   CEO need go New management Because Stock market kubis 10/27/17 01:13:53 PM
#335   MRK’s US Zostavax sales at risk: #msg-135689292. DewDiligence 10/25/17 02:08:32 PM
#333   MRK formally dumps Anacetrapib program: #msg-135326811. DewDiligence 10/11/17 06:55:47 PM
#331   It is one thing to find yourself, or boroborough 10/10/17 10:14:00 AM
#330   FDA approves Keytruda in third-line gastric cancer for DewDiligence 09/22/17 04:17:14 PM
#329   MRK acquires private I-O company for €115M up-front DewDiligence 09/06/17 08:38:38 AM
#328   MRK market cap = 173.51B -- Uh yeah, MiguelHammond10 09/06/17 08:17:38 AM
#327   Anacetrapib CVOT shows very modest clinical benefit: #msg-134215022. DewDiligence 08/29/17 09:50:18 AM
#326   A new daily high at $62.73 was just MiguelHammond10 08/14/17 05:26:38 AM
#325   MRK 2Q17 CC (edited) transcript: DewDiligence 07/29/17 09:48:28 AM
#324   Will MRK buy KTOV after the recent amazing biotechnician 07/28/17 07:53:43 AM
#323   Renflexis FoB priced at 35% discount to (JNJ's) DewDiligence 07/24/17 11:03:42 AM
#322   Nice opportunity in SYN waiting on FDA approval MiguelHammond10 07/24/17 04:45:50 AM
#321   http://www.cnn.com/2017/07/19/health/gupta-mccain-glioblastoma/index.html north40000 07/20/17 12:28:26 AM
#320   NEWS TODAY: Merck's Keytruda in combo with KTOV biotechnician 07/18/17 01:19:18 PM
#319   Stalking The Institutional Trade Level ITMS 07/17/17 11:44:48 AM
#318   https://seekingalpha.com/article/4086073-merck-good-long-term-despite-major-setb Inoviorulez 07/06/17 12:27:42 PM
#317   FDA places clinical hold on Keytruda trials in DewDiligence 07/05/17 04:59:04 PM
#315   ASCO webcast slides: DewDiligence 06/05/17 06:48:54 PM
#314   FDA approves Keytruda for solid tumors with high DewDiligence 05/23/17 03:09:50 PM
#313   FDA approves two sBLAs for Keytruda in bladder cancer: DewDiligence 05/18/17 01:11:08 PM
#312   MRK—FDA approves Keytruda/chemo in first-line NSCLC regardless of DewDiligence 05/10/17 05:34:09 PM
#311   Transcript of MRK 1Q17 CC on 5/2/17: DewDiligence 05/09/17 10:28:00 AM
#310   MRK reports 1Q17 results—raises 2017 guidance: DewDiligence 05/02/17 08:13:35 AM
#309   FDA approves Keytruda in r/r classical Hodgkin lymphoma: #msg-129517013. DewDiligence 03/14/17 06:17:52 PM
#308   FDA approves MRK’s Odactra for dust-mite allergy: DewDiligence 03/01/17 07:05:25 PM
#307   This is more than a mere accounting adjustment, DewDiligence 02/24/17 11:46:39 AM
#306   Merck & Co., Inc. (NYSE:MRK) In $2.9 Billion trendmkr 02/24/17 11:14:11 AM
#305   MRK effectively discontinues MK-3682, the HCV nucleoside obtained DewDiligence 02/23/17 06:52:11 PM
#304   MRK’s BACE Inhibitor for AD fails in mild-to-moderate DewDiligence 02/14/17 05:12:01 PM
#303   Net sales for Sivextro in 2016 were $14 jamtomorrow2 02/03/17 04:32:01 PM
#302   MRK appears to have a threshold of $500M DewDiligence 02/02/17 07:14:53 PM
#301   Sivextro sales 2016. As a Trius CVR jamtomorrow2 02/02/17 07:10:45 PM
#300   MRK reports 4Q16 results: DewDiligence 02/02/17 09:36:54 AM
#298   Bristol-Myers Squibb To Share In Sales Of Merck trendmkr 01/24/17 08:51:48 PM
#297   Merck & Co., Inc. And Palantir Technologies Inc trendmkr 01/18/17 11:28:13 AM
#296   Bryan, Garnier & Co started Merck & Co ValueInvestor15 01/13/17 02:09:40 PM
#295   MRK & NLNK ebola vax inventor now Chairman remind2 01/03/17 11:36:46 PM
#294   CHMP approves MRK’s Keytruda in first-line NSCLC with DewDiligence 12/17/16 11:03:34 AM
#293   More on same topic—(MRK-GILD patent case): #msg-127266273. DewDiligence 12/17/16 10:42:43 AM
PostSubject